Mapping the heart’s cellular blueprint: New insights into cardiac structure and disease repair

Researchers unveil the complex cellular architecture of the heart using advanced RNA sequencing and imaging techniques, shedding light on the intricate organization of heart cells and their developmental pathways.

Lowering the Target for Blood Pressure Is Best, Study Affirms

PHILADELPHIA — A systolic blood pressure treatment target under 120 mm Hg improved outcomes and saved lives compared with a threshold of 140 mm Hg

November 14, 2023

Drastic caloric restriction by athletes diminishes performance and compromises the immune system

Drastically cutting back on caloric intake to lose weight ahead of competition is commonplace among athletes.

July 15, 2024

Ubiquigent enters agreement with Astellas subsidiary, Nanna Therapeutics

Agreement leverages Ubiquigent’s DUB-focused drug discovery platform to support the development of novel therapeutic candidates for multiple disease targets selected by Nanna Therapeutics.

March 11, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.